Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients.

Elizabeth Parody-Rúa Alejandro Bustamante Joan Montaner Maria Rubio-ValeraDavid SerranoSoledad Pérez-Sánchez Alba Sánchez-Viñas César Guevara-Cuellar Antoni Serrano-Blanco

Published in: The European journal of health economics : HEPAC : health economics in prevention and care (2022)

The use of a blood biomarker test to guide pre-hospital thrombolysis is cost-effective compared with standard hospital care in patients with ischemic stroke.

Keyphrases

healthcare
pulmonary embolism
acute care
adverse drug
acute ischemic stroke
atrial fibrillation
stem cells
emergency department
pain management
human health